These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
1. CVS reported Q4 sales of $97.71 billion, surpassing expectations. 2. Adjusted EPS of $1.19 decreased from $2.12 year-over-year. 3. Analysts raised price targets after positive earnings, indicating confidence. 4. CVS expects fiscal 2025 adjusted EPS between $5.75 and $6.00.